395 related articles for article (PubMed ID: 12974897)
21. [Incidence and prevalence of autoimmune liver diseases].
Berdal JE; Ebbesen J; Rydning A
Tidsskr Nor Laegeforen; 1998 Nov; 118(29):4517-9. PubMed ID: 9889636
[TBL] [Abstract][Full Text] [Related]
22. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
23. The role of complement activation in autoimmune liver disease.
Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA
Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.
Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watanabe S; Senda S; Masaki T
Can J Gastroenterol; 2012 Mar; 26(3):125-9. PubMed ID: 22408762
[TBL] [Abstract][Full Text] [Related]
25. Medical and economic impact of autoimmune hepatitis.
Talwalkar JA; Kim WR
Clin Liver Dis; 2002 Aug; 6(3):649-67. PubMed ID: 12362573
[TBL] [Abstract][Full Text] [Related]
26. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of overlap syndromes.
Bunchorntavakul C; Reddy KR
Clin Liver Dis; 2015 Feb; 19(1):81-97. PubMed ID: 25454298
[TBL] [Abstract][Full Text] [Related]
28. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
29. Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases.
Huang W; Jin T; Zheng W; Yin Q; Yan Q; Pan H; Xu C
J Autoimmun; 2024 May; 145():103188. PubMed ID: 38458076
[TBL] [Abstract][Full Text] [Related]
30. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
31. The Pathogenesis of Autoimmune Liver Disease.
Arndtz K; Hirschfield GM
Dig Dis; 2016; 34(4):327-33. PubMed ID: 27170385
[TBL] [Abstract][Full Text] [Related]
32. Worldwide Incidence of Autoimmune Liver Disease.
Jepsen P; Grønbæk L; Vilstrup H
Dig Dis; 2015; 33 Suppl 2():2-12. PubMed ID: 26641102
[TBL] [Abstract][Full Text] [Related]
33. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.
Deneau M; Jensen MK; Holmen J; Williams MS; Book LS; Guthery SL
Hepatology; 2013 Oct; 58(4):1392-400. PubMed ID: 23686586
[TBL] [Abstract][Full Text] [Related]
34. The future of autoimmune liver diseases - Understanding pathogenesis and improving morbidity and mortality.
Engel B; Taubert R; Jaeckel E; Manns MP
Liver Int; 2020 Feb; 40 Suppl 1():149-153. PubMed ID: 32077605
[TBL] [Abstract][Full Text] [Related]
35. HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists.
Cassinotti A; Birindelli S; Clerici M; Trabattoni D; Lazzaroni M; Ardizzone S; Colombo R; Rossi E; Porro GB
Am J Gastroenterol; 2009 Jan; 104(1):195-217; quiz 194, 218. PubMed ID: 19098870
[TBL] [Abstract][Full Text] [Related]
36. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
[TBL] [Abstract][Full Text] [Related]
37. Concurrent autoimmune diseases in patients with autoimmune hepatitis.
Teufel A; Weinmann A; Kahaly GJ; Centner C; Piendl A; Wörns M; Lohse AW; Galle PR; Kanzler S
J Clin Gastroenterol; 2010 Mar; 44(3):208-13. PubMed ID: 20087196
[TBL] [Abstract][Full Text] [Related]
38. How genetic risk contributes to autoimmune liver disease.
Ellinghaus D
Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
[TBL] [Abstract][Full Text] [Related]
39. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
[TBL] [Abstract][Full Text] [Related]
40. Primary biliary cirrhosis in Brunei Darussalam.
Chong VH; Telisinghe PU; Jalihal A
Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):622-8. PubMed ID: 21134832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
